Author: Aravinth Kumar Jayabalan; Diane E. Griffin; Anthony K. L. Leung
Title: Alphavirus nsP3 ADP-ribosylhydrolase Activity Disrupts Stress Granule Formation Document date: 2019_6_20
ID: n8sjpcbs_44
Snippet: The copyright holder for this preprint (which was not peer-reviewed) is the author/funder. . https://doi.org/10.1101/629881 doi: bioRxiv preprint Page 19 SGs and non-membranous condensates are observed in many physiological and pathological contexts in virus infection, cancers and neurodegenerative diseases [1, [12] [13] [14] . Preclinical studies showed that PARP inhibitors reduce the number of non-membranous pathological aggregates in models of.....
Document: The copyright holder for this preprint (which was not peer-reviewed) is the author/funder. . https://doi.org/10.1101/629881 doi: bioRxiv preprint Page 19 SGs and non-membranous condensates are observed in many physiological and pathological contexts in virus infection, cancers and neurodegenerative diseases [1, [12] [13] [14] . Preclinical studies showed that PARP inhibitors reduce the number of non-membranous pathological aggregates in models of neurodegenerative disease [26, 30, 76] and PARG knockout flies revealed progressive neurodegeneration with observable cytoplasmic aggregates [77] . Consistent with these findings, our data showed that expression of wild-type nsP3, but not an ADP-ribosylhydrolase-deficient nsP3 mutant, can reduce the number of SG-like aggregates formed upon expression of the FUS protein mutant R495X, which is linked to an aggressive form of ALS. These data altogether suggest possible therapeutic options for reduction of non-membranous protein aggregates by lowering PAR levels, either through inhibiting PARP or increasing the ADP-ribosylhydrolase activity. Viruses: CHIKV 181/25 WT and mutant strains were prepared as described previously [69] . Viral stocks were grown in BHK21 cells and assayed by plaque formation in Vero cells.
Search related documents:
Co phrase search for related documents- adp ribosylhydrolase activity and als aggressive form: 1
- adp ribosylhydrolase activity and CHIKV virus: 1
- adp ribosylhydrolase activity and mutant wt: 1, 2, 3
- ADP ribosylhydrolase and aggressive form: 1
- ADP ribosylhydrolase and als aggressive form: 1
- ADP ribosylhydrolase and CHIKV virus: 1
- ADP ribosylhydrolase and mutant wt: 1, 2, 3
- aggressive form and als aggressive form: 1
- CHIKV virus and mutant wt: 1, 2
Co phrase search for related documents, hyperlinks ordered by date